Biomed Industries, Inc
Biomed Industries, Inc. develops and commercializes drug therapeutics for unmet needs across neurodegenerative, metabolic, cardiovascular, and rare diseases. Its clinical pipeline includes small-molecule and other drug candidates, an FDA-approved infusion system, and an AI-enabled platform using machine learning to support drug discovery and development.